The latest price target for Sotera Health (NASDAQ:SHC) was reported by Goldman Sachs on June 5, 2026. The analyst firm set a price target for $20.00 expecting SHC to rise to within 12 months (a possible 28.04% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for Sotera Health (NASDAQ:SHC) was provided by Goldman Sachs, and Sotera Health initiated their buy rating.

The last upgrade for Sotera Health Co happened on January 9, 2026 when Piper Sandler raised their price target to $24. Piper Sandler previously had a neutral for Sotera Health Co.

There is no last downgrade for Sotera Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sotera Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sotera Health was filed on June 5, 2026 so you should expect the next rating to be made available sometime around June 5, 2027.

While ratings are subjective and will change, the latest Sotera Health (SHC) rating was a initiated with a price target of $0.00 to $20.00. The current price Sotera Health (SHC) is trading at is $15.62, which is within the analyst’s predicted range.